Felix Sahm is neuropathologist at the Dept. of Neuropathology at the University Hospital Heidelberg and head of the molecular diagnostics branch of the department. Currently, he investigates the molecular landscape of meningioma in order to integrate molecular markers into diagnostic work-up and treatment decisions, starting with the recently implemented DNA methylation-based grading approach to meningioma.